Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma
Veterinary and Comparative Oncology · 2026-09 · 24 (3) · 485-498
DOI: 10.1111/vco.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 19.04.2026. Verfasst von Victoria Lee Newberry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Dog Diseases, Liver Neoplasms, Carcinoma, Hepatocellular, Radiosurgery. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 stomach/small intestinal AE. Additionally, 70% of patients experienced late AE, with the majority being VRTOG grade 2 stomach/small intestinal AE. Liver‐specific side effects were also observed following SBRT, including VCOG‐CTCAE grade 4 hepatic encephalopathy and grade 5 liver failure. There was a statistically significant correlation between the gross tumour volume (GTV) and the overall survival time (OST; p = 0.02) as well as a significant correlation between the percentage of normal liver affected by the mass and the severity of acute stomach/small intestinal AE ( p = 0.01). Statistically significant correlations were observed between the dose of radiation to the normal liver, starting with a threshold dose of 7 Gy, and an increase of the liver enzyme ALT. Median survival time (MST) of the cohort was 301 days. Dogs with > 28.7% of the liver affected by the mass had a MST of 182 days vs. 419 days for dogs with < 28.7% affected ( p = 0.009). This study suggests parameters for GTV, percentage of liver affected, and dose to normal liver could affect survival and the likelihood for adverse effects and liver enzyme elevation when treating with SBRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
- Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
ORCID-Profile: Mary-Keara Boss, Tiffany W Martin
Zitieren
APA
Newberry, V. L., Boss, M. K., Leary, D., & Martin, T. W. (2026). Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma. Veterinary and Comparative Oncology, 24(3), 485-498. https://doi.org/10.1111/vco.70071
Vancouver
Newberry VL, Boss MK, Leary D, Martin TW. Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma. Veterinary and Comparative Oncology. 2026;24(3):485-498. doi:10.1111/vco.70071
BibTeX
@article{Newberry2026,
author = {Newberry, Victoria Lee and Boss, Mary-Keara and Leary, Del and Martin, Tiffany W},
title = {Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma},
journal = {Veterinary and Comparative Oncology},
year = {2026},
volume = {24},
number = {3},
pages = {485--498},
doi = {10.1111/vco.70071}
}
EUVIMED